During the past decade, Xinjiang People's Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Xinjiang People's Hospital" are "Pulmonary Embolism" (2 trials), "Thromboembolism" (2 trials), "Atrial Septal Defect" (1 trials), "Thrombosis" (1 trials) and "Vascular Diseases" (1 trials). Many other conditions were trialed in "Xinjiang People's Hospital" in a lesser frequency.

Most popular intervention types in "Xinjiang People's Hospital" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cook lunderquist guidewire" (1 trials), "Guidewire for echo-guided interventions" (1 trials), "Nadroparin" (1 trials), "Unfractionated heparin(UFH)" (1 trials) and "Urokinase" (1 trials). Other intervention names were less common.

The vast majority of trials in "Xinjiang People's Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Xinjiang People's Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Xinjiang People's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Xinjiang People's Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".